Vabysmo Is Bright Spot For Roche In Bumpy Q3

Anticipation Grows On Alzheimer’s Result

 
• By Andrew McConaghie
  
Roche_White_Logo
Roche got a big boost from its COVID-19 therapies last year, but does not expect further sales spikes, despite the unpredictability of SARS-CoV2. • Source: Shutterstock

More from Earnings

More from Business